CCL2 and neoplasm: In vitro inhibition of CCL2 in these cancers has been found to inhibit a number of important metastatic mechanisms, such as reducing angiogenesis, decreasing tumor cell proliferation, ameliorating immunosuppression, reducing tumor resistance to chemotherapy, and reversing polarization of immune cells that would otherwise promote cancer progression11–14.